Neuroplasticity and Mechanisms of Action of Acute and Chronic Treatment with Antidepressants in Preclinical Studies
Pharmacotherapy for depression includes drugs such as monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), noradrenaline (NA) and serotonin (5-HT) reuptake inhibitors (NaSSAs), and atypical antidepressants; these drugs exert differe...
        Saved in:
      
    
          | Main Authors: | Gilberto Uriel Rosas-Sánchez, León Jesús Germán-Ponciano, Gabriel Guillen-Ruiz, Jonathan Cueto-Escobedo, Ana Karen Limón-Vázquez, Juan Francisco Rodríguez-Landa, César Soria-Fregozo | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | MDPI AG
    
        2024-11-01 | 
| Series: | Biomedicines | 
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/12/12/2744 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Neuroplasticity in Depressive Disorders: The Role of BDNF in Linking Pharmacotherapy and Physical Activity        
                          
 by: Maciej Mamczur, et al.
 Published: (2024-12-01)
- 
                
                    Neuroinflammation and major depressive disorder: astrocytes at the crossroads        
                          
 by: Melissa Puentes-Orozco, et al.
 Published: (2024-11-01)
- 
                
                    Editorial: Neuroplasticity in multiple sclerosis        
                          
 by: Yavor Yalachkov, et al.
 Published: (2025-02-01)
- 
                
                    Genetic assimilation in the evolution of hominin neuroplasticity        
                          
 by: Luiz do Valle Miranda
 Published: (2019-06-01)
- 
                
                    Effects of neuroleptics and antidepressants on the cardiovascular system: literature review        
                          
 by: V. Rutkauskas
 Published: (2019-09-01)
 
       